初诊急性髓系白血病患者十种常见突变基因的突变组分析
作者：王芳， 张阳， 陈雪， 房建成， 王茫桔， 滕文， 韩香萍， 尹青， 许媛丽
作者单位：王芳,张阳,陈雪,房建成,滕文,韩香萍,尹青,许媛丽(河北燕达医院陆道培血液·肿瘤中心, 廊坊,065201)， 王茫桔(065201 廊坊,河北燕达医院陆道培血液·肿瘤中心;北京大学第一医院血液科)
刊名：
白血病·淋巴瘤
英文刊名：Journal of Leukemia & Lymphoma
年，卷(期)：2015,24(3)
1.刘红星肿瘤突变组研究进展和靶向鸡尾酒疗法的美好前景[期刊论文]-中国处方药 2013(04)
2.Khasawneh MK,Abdel-Wahab O.Recent discoveries in molecular characterization of acute myeloid leukemia[J].Curr Hematol Malig Rep,2014,9 (2):93-99. 2014
3.王芳,张阳,陈雪,等.白血病基因突变研究和应用进展:第56届美国血液学会年会报道[J].白血病·淋巴瘤,2015,24(3):157-160. 2015
4.Naoe T,Kiyoi H.Gene mutations of acute myeloid leukemia in the genome era[J].In t J Hematol,2013,97 (2):165-174. 2013
5.沈杨,陈赛娟急性白血病基因突变与多步骤发病机制和临床相关性[期刊论文]-中国科学（生命科学） 2013(01)
6.Huang Y,Rao A.Connections between TET proteins and aberrant DNA modification in cancer[J].Trends Genet,2014,30 (10):464-474. 2014
7.Krauth MT,Alpermann T,Bacher U,et al.WT1 mutations are secondary events in AML,show varying frequencies and impact on prognosis between genetic subgroups[J].Leukemia,2015,29(3):660-667. 2015
8.Welch JS,Ley TJ,Link DC,et al.The origin and evolution of mutations in acute myeloid leukemia[J].Cell,2012,150 (2):264-278. 2012
9.Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J].Cell,2011,144 (5):646-674. 2011
10.Tomasetti C,Vogelstein B.Cancer etiology.Variation in cancer risk among tissues can be explained by the number of stem cell divisions[J].Science,2015,347 (6217):78-81. 2015
11.Janke H,Pastore F,Schumacher D,et al.Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia[J].PLoS
One,2014,9(3):e89560. 2014
12.Wang YY,Zhao LJ,Wu CF,et al.C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice[J].Proc Natl Acad Sci U S A,2011,108 (6):2450-2455. 2011
13.Sottoriva A,Kang H,Ma Z,et al.A Big Bang model of human colorectal tumor growth[J].Nat Genet,2015,47 (3):209-216. 2015
14.Schnittger S,Schoch C,Dugas M,et al.Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:correlation to cytogenetics,FAB subtype,and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease[J].Blood,2002,100(1):59-66. 2002
15.Manara E,Bisio V,Masetti R,et al.Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial:screening and prognostic impact of c-KIT mutations[J].Leukemia,2014,28(5):1132-1134. 2014 16.Dohner K,Schlenk RF,Habdank M,et al.Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:interaction with other gene mutations[J].Blood,2005,106
(12):3740-3746. 2005
17.Wouters B J,Lowenberg B,Erpelinck-Verschueren CA,et al.Double CEBPA mutations,but not single CEBPA
mutations,define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome[J].Blood,2009,113(13):3088-3091. 2009
18.Renneville A,Boissel N,Gachard N,et al.The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal
duplication[J].Blood,2009,113 (21):5090-5093. 2009
19.Port M,Bottcher M,Thol F,et al.Prognostic significance of FLT3 internal tandem duplication,nucleophosmin 1,and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years:a systematic review and meta-analysis[J].Ann Hematol,2014,93 (8):1279-1286. 2014
20.王凌燕急性白血病中核仁磷酸蛋白异常表达的研究进展[期刊论文]-白血病·淋巴瘤 2014(12)
21.Corces-Zimmerman MR,Hong WJ,Weissman IL,et al.Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission[J].Proc Natl Acad Sci,2014,111 (7):2548-2553. 2014
22.Zhang L,Padron E,Lancet J.The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes[J].Leuk Res,2015,39 (1):6-17. 2015
引用本文格式：王芳.张阳.陈雪.房建成.王茫桔.滕文.韩香萍.尹青.许媛丽初诊急性髓系白血病患者十种常见突变基因的突变组分析[期刊论文]-白血病·淋巴瘤 2015(3)。